The pNN50 HRV measure was marginally significant for the cell type main effect and reflected lower PNS activity in the participant associated with providing treatment to live pancreatic cancer cells versus dead cells/medium-no cells.
← all excerpts
Examining the effects of biofield therapy through simultaneous assessment of electrophysiological and cellular outcomes.
1
—
—